Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty and Zucker rats

American Journal of Physiology - Endocrinology and Metabolism

Volumn 289, Issue 1 52-1, 2005, Pages

  Oltman, Christine L ^a   Coppey, Lawrence J ^a   Gellett, Jill S ^a   Davidson, Eric P ^a   Lund, Donald D ^a   Yorek, Mark A ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Diabetic neuropathy; Metabolic syndrome; Oxidative stress; Superoxide; Type 2 diabetes; Vascular reactivity

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; FATTY ACID; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FATTY ACID BLOOD LEVEL; GLUCOSE INTOLERANCE; HYPERGLYCEMIA; HYPERINSULINEMIA; LIFESPAN; MALE; NERVE CONDUCTION; NERVE FIBER MEMBRANE; NEUROLOGIC DISEASE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RAT STRAIN; SCIATIC NERVE; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR DISEASE; VASODILATATION;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CALCITONIN GENE-RELATED PEPTIDE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEUROPATHIES; DISEASE PROGRESSION; HYPERGLYCEMIA; HYPERLIPIDEMIAS; INSULIN; MALE; METABOLIC SYNDROME X; NEURAL CONDUCTION; OBESITY; RATS; RATS, ZUCKER; SCIATIC NEUROPATHY;

EID: 21044459538     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00594.2004     Document Type: Article

References (50)

1. 2+ signaling pathways. Mol Cell Biochem 197: 179-185. 1999.
2. Alderson NL, Chachich ME, Youssef NN, Beattie RJ, Nachtigal M, Thorpe SR, and Baynes JW. The AGE inhibitor pyridoxamine inhibits lipemia and development of renal an vascular disease in Zucker obese rats. Kidney Int 63: 2123-2133, 2003.
3. Appenzeller O, Dhital KK, Cowen T, and Burnstock G. The nerves to blood vessels supplying blood to nerves: the innervation of vasa nervorum. Brain Res 304: 383-386, 1984.
4. Beckman JS. Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 9: 836-844, 1996.
5. Bray GA. The Zucker-fatty rat: a review. Fed Proc 36: 148-153, 1977.
6. Ceriello A, Taboga C, Tonutti L, Quagliaro L, Piconi L, Bais B, Da Ros R, and Motz E. Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simuvastatin treatment. Circulation 106: 1211-1218, 2002.
7. Champion HC, Bivalacqua TJ, Pierce RL, Murphy WA, Coy DH, Hyman AL, and Kadowitz PJ. Responses to human CGRP, ADM, and PAMP in human thymic arteries. Am J Physiol Regul Integr Comp Physiol 284: R531-R537, 2003.
8. Coppey LJ, Davidson EP, Dunlap JA, Lund DD, and Yorek MA. Slowing of motor nerve conduction velocity in streptozotocin-induced diabetic rats is preceded by impaired vasodilation in arterioles that overlie the sciatic nerve. Int J Exp Diabetes Res 1: 131-143, 2000.
9. Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Lund DD, and Yorek MA. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes 50: 1927-1937, 2001.
10. Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, and Yorek MA. Changes in endoneurial blood flow, motor nerve conduction velocity and vascular relaxation of epineurial arterioles of the sciatic nerve in ZDF-obese diabetic rats. Diab/Metab Res Rev 18: 49-56, 2002.
11. Coppey LJ, Gellett JS, Davidson EP, and Yorek MA. Preventing superoxide formation in epineurial arterioles of the sciatic nerve from diabetic rats restores endothelium-dependent vasodilation. Free Radic Res 37: 33-40, 2003.
12. DeFonzo RA. The triumvirate: β-cell, muscle and liver. A collusion responsible for NIDDM. Diabetes 37: 667-687, 1988.
13. Diemel LT, Stevens EJ, Willars GB, and Tomlinson DR. Depletion of substance P and calcitonin gene-related peptide in sciatic nerve of rats with experimental diabetes: effects of insulin and aldose reductase inhibition. Neurosci Lett 137: 253-256, 1992.
14. Erdos B, Simandle SA, Snipes JA, Miller AW, and Busija DW. Potassium channel dysfunction in cerebral arteries of insulin-resistant rats is mediated by reactive oxygen species. Stroke 35: 964-969, 2004.
15. Erdos B, Snipes JA, Miller AW, and Busija DW. Cerebrovascular dysfunction in Zucker obese rats is mediated by oxidative stress and protein kinase C. Diabetes 53: 1352-1359, 2004.
16. Farrar NS, Chambers NJ, Carlsson AR, Denyer G, and Johnston GA. Effect of a series of novel sulphonylthioureas on glucose tolerance in the obese fa/fa Zucker rat. Clin Exp Pharmacol Physiol 28: 386-394, 2001.
17. Hasbak P, Opgaard OS, Eskesen K, Schifter S, Arendrup H, Longmore J, and Edvinsson L. Investigation of CGRP receptors and peptide pharmacology in human coronary arteries. Characterization with a non-peptide antagonist. J Pharmacol Exp Ther 304: 326-333, 2003.
18. 2+-decrease. J Membr Biol 232: 1017-1025. 2002.
19. Kava R, Greenwood MR, and Johnson PR. Zucker (fa/fa) rats. ILAR News 32: 4-8, 1990.
20. Kihara M and Low PA. Regulation of rat nerve blood flow: role of epineurial alpha-receptors. J Physiol 422: 145-152, 1990.
21. Kurtz TW, Morris RC, and Pershadsingh HA. The Zucker fatty rat as a genetic model of obesity and hypertension. Hypertension 13: 896-901, 1989.
22. Ma Chabot JG W, Powell KJ, Jhamandas K, Dickerson IM, and Quirion R. Localization and modulation of calcitonin gene-related peptide-receptor component protein-immunoreactive cells in the rat central and peripheral nervous systems. Neuroscience 120: 677-694, 2003.
23. Mihara M, Uchiyama M, and Fukuzama K. Thiobarbituric acid value of fresh homogenate of rat as a parameter of lipid peroxidation in aging. CC14 intoxication, and vitamin E deficiency. Biochem Med 23: 302-311, 1980.
24. Miller AW, Tulbert CD, and Busija DW. Rosuvastatin treatment reverses impaired coronary artery vasodilation in fructose-fed rats. Am J Physiol Regul Integr Comp Physiol 287: R157-R160, 2004.
25. Miller FJ, Gutterman DD, Rios CD, Heistad DD, and Davidson BL. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 82: 1298-1305, 1998.
26. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, and Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage. Nature 404: 787-790, 2000.
27. Peterson RG, Shaw WN, Neel MA, Little LA, and Eichberg J. Zucker diabetic fatty rat as a model for non-insulin-dependent diabetes mellitus. ILAR News 32: 16-19, 1990.
28. Peterson RG, Neel MA, Little LA, Kincaid JC, and Eichberg J. Neuropathic complications in the Zucker diabetic fatty rat (ZDF/Drt-fa). In: Frontiers in Diabetes Research. Lessons from Animal Diabetes III, edited by Shafrir E. London, UK: Smith-Gordon, 1990, p. 456-458.
29. Pryor WA and Squadrito GI. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol Lung Cell Mol Physiol 268: L699-L722, 1995.
30. Qiu J, Steyger PS, Trune DR, and Nuttall AL. Co-existence of tyrosine hydroxylase and calcitonin gene-related peptide in cochlear spiral modiolar artery of guinea pigs. Hear Res 155: 152-160, 2001.
31. Ran J, Hirano T, and Adachi M. Angiotensin II type I receptor blocker ameliorates overproduction and accumulation of triglyceride in the liver of Zucker fatty rats. Am J Physiol Endocrinol Metab 287: E227-E232, 2004.
32. Rechthand Hervonen A, Sato SE, and Rapoport SI. Distribution of adrenergic innervation of blood vessels in peripheral nerve. Brain Res 374: 185-189, 1986.
33. Rossi SG, Dickerson IM, and Rotundo RL. Localization of the calcitonin gene-related peptide receptor complex at the vertebrate neuromuscular junction and its role in regulating acetylcholinesterase expression. J Biol Chem 278: 24994-25000, 2003.
34. Shafrir E. Animal models of non-insulin-dependent diabetes. Diabetes Metab Rev 8: 179-208, 1992.
35. Sheykhzade M, Berg M, and Nyborg NC. Mechanism of CGRP-induced relaxation in rat intramural coronary arteries. Br J Pharmacol 132: 1235-1246, 2001.
36. Shinozaki K, Kashiwagi A, Masada M, and Okamura T. Stress and vascular responses: oxidative stress and endothelial dysfunction in the insulin-resistant state. J Pharm Sci 91: 187-191, 2003.
37. Siman CM and Eriksson UJ. Vitamin C supplementation of the maternal diet reduces the rate of malformation in the offspring of diabetic rats. Diabetologia 40: 1416-1424, 1997.
38. Singleton JR, Smith AG, Russell JW, and Feldman EL. Microvascular complications of impaired glucose tolerance. Diabetes 52: 2867-2873, 2003.
39. Smith SA, Lister CA, Toseland CDN, and Buckingham RE. Rosiglitazone prevents the onset of hyperglycemia and proteinuria in the Zucker diabetic fatty rat. Diabetes Obesity Metab 1: 363-372, 2000.
40. Sonta T, Inoguchi T, Tsubouchi H, Sekiguchi N, Kobayashi K, Matsumoto S, Utsumi H, and Nawata H. Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity. Free Radic Biol Med 37: 115-123, 2004.
41. Terata K, Coppey LJ, Davidson EP, Dunlap JA, Gutterman DD, and Yorek MA. Acetylcholine-induced arteriolar dilation is reduced in streptozotocin-induced diabetic rats with motor nerve dysfunction. Br J Pharmacol 128: 837-843, 1999.
42. Toblli JE, DeRosa G, Cao G, Piorno P, and Pagano P. ACE inhibitor and angiotensin type I receptor antagonist in combination reduce renal damage in obese Zucker rats. Kidney Int 65: 2343-2359, 2004.
43. Tomlinson DR, Fernyhough P, and Diemel LT. Neurotrophins and peripheral neuropathy. Philosoph Trans Royal Soc Lond 351: 455-462. 1996.
44. Tomlinson DR, Fernyhough P, and Diemel LT. Role of neurotrophins in diabetic neuropathy and treatment with nerve growth factors. Diabetes 46: S43-S49, 1997.
45. Triggle CR, Ding H, Anderson TJ, and Pannirselvam M. The endothelium in health and disease: a discussion of the contribution of non-nitric oxide endothelium-derived vasoactive mediators to vascular homeostasis in normal vessels and in type II diabetes. Mol Cell Biochem 263: 21-27, 2004.
46. Wattanapitayakul SK, Weinstein DM, Holycross BJ, and Bauer JA. Endothelial dysfunction and peroxynitrite formation are early events in angiotensin-induced cardiovascular disorders. FASEB J 14: 271-278, 2000.
47. Yorek MA, Coppey LJ, Gellett JS, and Davidson EP. Sensory nerve innervation of epineurial arterioles of the sciatic nerve containing calcitonin gene-related peptide: effect of streptozotocin-induced diabetes. Exp Diab Res 5: 187-193, 2004.
48. +-ATPaSe activity in rats maintained on L-fucose diet. Diabetes 42: 1401-1406, 1993.
49. 2 clearance measurement of blood flow: a review of technique and polarographic principles. Stroke 11: 552-564, 1980.
50. Zochodne DW and Ho LT. Unique microvascular characteristics of the dorsal root ganglion in the rat. Brain Res 559: 89-93, 1991.